Treatment Expectations and Patient Conversations in Atopic Dermatitis

Author(s):

Raj Chovatiya, MD, PhD,George Han, MD, PhD

Key Takeaways

Setting treatment expectations is vital for building trust and aligning patient-physician goals in oncology.
Continuous dialogue about treatment targets keeps patients informed and engaged in their care.
Treatment decisions are based on clinical evidence, patient response, and individual preferences.
Oncologists consider disease progression, side effects, and quality of life when choosing treatment paths.

Medical experts discuss the importance of setting treatment expectations and maintaining dialogue with patients about targets and explain how to decide on a new treatment when switching.

EP: 1.JAK Inhibitors and Pathophysiology of Atopic Dermatitis

EP: 2.Oral JAK inhibitors and Their Use for Treatment of Atopic Dermatitis

EP: 3.Oral JAK Inhibitor Use in Atopic Dermatitis: Screening and Monitoring Patients

EP: 4.Long-term Safety Data for JAK Inhibitors in Atopic Dermatitis

EP: 5.Utilizing Long-Term Atopic Dermatitis Data in Clinical Practice

EP: 6.Data on Early Itch Relief with JAK Inhibitors in Atopic Dermatitis

EP: 7.Speed of Itch Relief in Atopic Dermatitis

EP: 8.Systemic Treatments and Switching Therapy in Atopic Dermatitis

Now Viewing

EP: 9.Treatment Expectations and Patient Conversations in Atopic Dermatitis

EP: 10.Switching from Biologics to JAK Inhibitors in Atopic Dermatitis: Clinical Data

EP: 11.Treatment Breaks and Rescue Treatments in Atopic Dermatitis

EP: 12.Switching patients to JAK Inhibitors in Atopic Dermatitis in Clinical Practice

EP: 13.Treatment Flexibility While on Abrocitinib in Atopic Dermatitis (JADE REGIMEN)

EP: 14.Future Outlook for Atopic Dermatitis Treatments

Video content above is prompted by the following:

How important is it to set treatment expectations? Do you have an ongoing dialogue with patients about achieving targets?
How do you determine which treatment to switch to?